T. Rowe Price Associates’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1M | Sell |
|
|||||
|
2024
Q4 | $1.69M | Sell |
|
|||||
|
2024
Q3 | $2.02M | Sell |
|
|||||
|
2024
Q2 | $1.1M | Sell |
|
|||||
|
2024
Q1 | $2.63M | Sell |
|
|||||
|
2023
Q4 | $24.8M | Sell |
|
|||||
|
2023
Q3 | $27.1M | Sell |
|
|||||
|
2023
Q2 | $36.3M | Buy |
|
|||||
|
2023
Q1 | $33.6M | Sell |
|
|||||
|
2022
Q4 | $17.6M | Sell |
|
|||||
|
2022
Q3 | $52.5M | Sell |
|
|||||
|
2022
Q2 | $22.4M | Buy |
|
|||||
|
2022
Q1 | $23.1M | Buy |
|
|||||
|
2021
Q4 | $50.7M | Buy |
|
|||||
|
2021
Q3 | $81.2M | Buy |
|